Mediaspace scheduled maintenance: Aug 25, 2026 07:00 - 12:00 AM. During this time, videos will be temporarily unavailable. Check status updates.
Traditional analog front-ends for biomedical signal acquisitions operate at very low frequencies (Hz-range) and are severely affected by flicker and environmental noise, which degrade the quality of low-frequency signals, thereby reducing the signal-to-noise ratio (SNR). While offering advantages, the increasingly common use of microelectrodes poses challenges due to their low-frequency high impedance, which is comparable to the one of the front-end, thus creating additional difficulties in signal acquisition. To tackle the challenges of in-vitro low-frequency biosignal acquisition, this letter proposes a novel methodology based on the upconversion of low-frequency biosignals to a higher frequency band by a Schottky diode immersed in a solution. This letter aims to demonstrate the feasibility of the new sensory method by translating in frequency the information of a sinewave stimulus representing a biological signal. Experimental results showed a conversion loss of 11.11 dB and demonstrated the upconverted signal propagation in the solution, measuring an intermodulation power above the noise floor, from -87.04 to -104.13 dBm. The proposed method provides a better signal-to-noise ratio than the traditional acquisition method, estimating an improvement of 8.99 dB.
David Atienza Alonso, Giovanni Ansaloni, Pasquale Davide Schiavone, Juan Pablo Sapriza Araujo
Olaf Blanke, Bruno Herbelin, Nathaniel Evans, Bastien Orset
Henry Markram, Werner Alfons Hilda Van Geit, Tanguy Pierre Louis Damart, Darshan Mandge, Aurélien Tristan Jaquier, Mickael Maurice Zbili